$TLSI 4 SEC Filings

Filed On	Filing
07 Oct 2026	Form 4: Cox Bryan F., Chief of Research Sold 296 shares ($1.3K)
07 Oct 2026	Form 4: Marshak Richard, Chief Commercial Officer Sold 325 shares ($1.43K)
07 Oct 2026	Form 4: Stevens Jennifer, Chief Regulatory Officer Sold 316 shares ($1.39K)
07 Oct 2026	Form 4: Szela Mary T, Director Gave up 2,693 shares to cover exercise price or tax ($11.8K)
06 Jul 2026	Form 4: Patience David, Chief Financial Officer Gave up 14,650 shares to cover exercise price or tax ($65.3K)
01 Jul 2026	Form 4: Szela Mary T, Director Received 3,990 shares as a grant or award ($15.4K)
01 Jul 2026	Form 4: Marshak Richard, Chief Commercial Officer Received 561 shares as a grant or award ($2.17K)
29 Jun 2026	Form 4: Marshall Richard Henry, Chief Medical Officer Received 60,000 shares as a grant or award · Granted 120,000 Employee Stock Option (right to buy)
19 May 2026	Form 4: Marshak Richard, Chief Commercial Officer Sold 543 shares ($1.45K)
18 May 2026	Form 4: Wahlstrom Mats, Director Bought 60,000 shares ($152K)
18 May 2026	Form 4: Stansky Michael P, Director Bought 610,000 shares ($1.53M)
18 May 2026	Form 4: Szela Mary T, Director Bought 39,682 shares ($103K)
18 May 2026	Form 4: Patience David, Chief Financial Officer Bought 7,100 shares ($17.3K)
18 May 2026	Form 4: Gordon Gary B., Director Bought 10,000 shares ($24.6K)
15 May 2026	Form 4: Hicks Kerry R, Director Received 28,201 shares as a grant or award · Granted 56,403 Director Stock Option (right to buy)
15 May 2026	Form 4: Wahlstrom Mats, Director Received 71,828 shares as a grant or award · Granted 75,204 Director Stock Option (right to buy)
15 May 2026	Form 4: Gordon Gary B., Director Received 52,754 shares as a grant or award · Granted 56,403 Director Stock Option (right to buy)
15 May 2026	Form 4: Matlin David J, Director Received 51,266 shares as a grant or award · Granted 56,403 Director Stock Option (right to buy)
15 May 2026	Form 4: Valle William, Director Received 52,754 shares as a grant or award · Granted 56,403 Director Stock Option (right to buy)
15 May 2026	Form 4: Stansky Michael P, Director Received 43,590 shares as a grant or award · Granted 47,003 Director Stock Option (right to buy)

Comments